Repligen Corp. (RGEN)
128.73
-4.92
(-3.68%)
USD |
NASDAQ |
Feb 27, 16:00
128.67
-0.06
(-0.05%)
After-Hours: 20:00
Repligen Research and Development Expense (TTM) : 52.44M for Dec. 31, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Orthofix Medical, Inc. | 65.85M |
| InfuSystem Holdings, Inc. | -- |
| Abbott Laboratories | 2.89B |
| Accuray, Inc. | 44.10M |
| Plus Therapeutics, Inc. | 7.624M |